
A lean, mean money-machine.
Officially speaking, Novo Nordisk probably would not care to be associated with the slightly rewritten battle-cry of the lean, mean killing-machines of the American Marine Corps. But the Danish pharmaceutical group is just that; a lean, ruthless money-machine, that seems to generate profit no matter what and devour rivals for breakfast.
Allerede abonnent? Log ind.
Læs hele artiklen
Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app